Assay Development

TECHNOLOGY AGNOSTIC APPROACH

At Pathway Diagnostics, we are focused on biomarker assay development in cardiovascular diseases, oncology, inflammatory and autoimmune diseases, infectious diseases and psychiatric disorders. We provide assay development services for multiple types of biomarkers, including proteins, nucleic acids, carbohydrates and lipids. Our "technology agnostic" approach offers a variety of platforms and expert consultative services to facilitate the selection of the technology that best meets study objectives. We optimize our biomarker assay development services to meet clients' internal validation specifications, regulatory requirements and potential commercialization needs.